RUNX2 and head and neck squamous cell carcinoma: Since no correlation of RUNX2 and RanBP17 gene expression was seen in the HPV+ HNSCC group, the observed positive prognostic effect in the RanBP17high patient population of the HPV+ group does not seem to be dependent on the miR-635/RUNX2 axis.